Nu Skin Enterprises, Inc. (NUS - Free Report) released second-quarter 2019 results, with earnings meeting the Zacks Consensus Estimate and sales missing the same. The top and the bottom line also declined year on year.
The quarterly performance was affected by headwinds in Mainland China. The recently completed 100-day government campaign in the region to inspect offerings of nutrition and direct sales industry led to adversities such as limited sales meetings, media scrutiny and unfavorable consumer sentiments. These factors exerted pressure on the company’s top and the bottom line in the reported quarter.
Nu Skin delivered quarterly earnings of 83 cents a share, in line with the Zacks Consensus Estimate. However, the bottom line declined 7.7% from the year-ago quarter’s reported figure.
Revenues of $623.5 million missed the Zacks Consensus Estimate of $633.2 million and declined nearly 11.5% from the prior-year quarter’s level. The metric includes a negative impact of 4% (or approximately $31 million) from foreign currency fluctuations. On a constant-currency basis, the top line declined 7%.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Sales leaders fell 14% year over year to reach 61,563, with Mainland China accounting for the majority of the decline. In fact, sales leaders deteriorated in most regions except South Korea and Hong Kong/Taiwan regions.
Nevertheless, Nu Skin’s customer base inched up 1% to 1,160,420 on growth in Mainland China, Southeast Asia and EMEA regions.
Gross profit came in at $469.5 million, down about 12.3% from the year-ago quarter’s tally. Gross margin contracted 80 basis points (bps) to 75.3% thanks to foreign currency headwinds and higher percentage of manufacturing platform revenues. These were partially cushioned by cost savings. Core Nu Skin gross margin slipped 10 bps to 77.8%.
Selling expenses amounted to $245.8 million, which accounted 39.4% of revenues compared with 38.7% in the year-ago quarter. Meanwhile, general and administrative expenses of $149.4 million accounted for 24% of revenues, down from 25.6% in the year-ago quarter
Operating income declined 10.4% to $74.2 million, primarily due to lower revenues. Operating margin increased 10 bps to 11.9%.
Revenues declined across most regions, except Japan. Sales in the region improved 2% from the prior-year quarter’s level. The highest decline was witnessed in Mainland China, where the metric declined 24%. Further, revenues fell 11% in Americas/Pacific, 8% in South Korea, 5% in Southeast Asia, 16% in Hong Kong/Taiwan and 1% in EMEA.
Other Financial Details
Nu Skin ended the quarter with cash and cash equivalents of $360.6 million, long-term debt of $349 million and stockholders' equity of $835 million.
During the quarter, the company paid out dividends of $20.6 million.
Nu Skin is on track with initiatives to improve matters in Mainland China. In this context, the company plans to roll out products, sales strategies and manufacturing platforms. Additionally, it is progressing well with efforts to augment customer base at other locations.
That said, management reiterated its guidance for 2019, which was provided on Jul 16. It expects revenues in the range of $2.48-$2.52 billion, including currency headwinds of nearly 3-4%. The top-line projection indicates a decline of 6-8% from the year-ago quarter’s tally.
Further, earnings are projected in the range of $3.20-$3.35, indicating a decline from $3.52 delivered in the prior year. The Zacks Consensus Estimate for earnings in 2019 is currently pegged at $3.27.
For the third quarter, the company projects revenues in the band of $595-$615 million, including adverse currency impacts of nearly 2%. The projection suggests a decline of almost 9-12% from the year-ago quarter’s tally. Earnings are anticipated between 74 cents and 81 cents. The Zacks Consensus Estimate for third-quarter earnings is currently pegged at 79 cents.
Shares of this Zacks Rank #5 (Strong Sell) company have plunged 30.6% in the past three months against the industry’s rise of 0.6%.
Looking for More Consumer Staples Stocks? Check These
Estee Lauder (EL - Free Report) , with a Zacks Rank #2 (Buy), has long-term earnings growth rate of 13%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
McCormick & Company (MKC - Free Report) , with a Zacks Rank #2, has long-term earnings growth rate of 8%.
General Mills (GIS - Free Report) , with an expected long-term earnings growth rate of 7%, also carries a Zacks Rank #2.
This Could Be the Fastest Way to Grow Wealth in 2019
Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.
These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.
Click here to see these breakthrough stocks now >>